PPA
KIN

Parametric Portfolio Associates’s Kindred Biosciences, Inc. KIN Stock Holding History

Parametric Portfolio Associates’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,498
Closed -$179K – 3714
2021
Q2 		$179K Sell
19,498
-7,157
-27% -$41.6K ﹤0.01% 3426
2021
Q1 		$132K Buy
26,655
+752
+3% +$3.63K ﹤0.01% 3943
2020
Q4 		$112K Buy
25,903
+689
+3% +$2.8K ﹤0.01% 3874
2020
Q3 		$108K Sell
25,214
-1,636
-6% -$6.84K ﹤0.01% 3783
2020
Q2 		$121K Sell
26,850
-48,957
-65% -$219K ﹤0.01% 3743
2020
Q1 		$303K Sell
75,807
-35,102
-32% -$298K ﹤0.01% 3397
2019
Q4 		$941K Buy
110,909
+13,341
+14% +$104K ﹤0.01% 3094
2019
Q3 		$668K Buy
97,568
+61,684
+172% +$452K ﹤0.01% 3232
2019
Q2 		$299K Buy
+35,884
New +$310K ﹤0.01% 3586

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Parametric Portfolio Associates's KIN Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 19,498 shares — an estimated $179K sold.

Parametric Portfolio Associates first reported a position in KIN in Q2 2019 and held it in 9 quarters. The position peaked at $941K in Q4 2019. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 19,498 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $179K.
  • Parametric Portfolio Associates first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 9 quarters.
  • Parametric Portfolio Associates's Kindred Biosciences, Inc. position peaked at $941K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.